WO2023186084A1 - Dispositif à puce et instrument pour la détection d'acide nucléique, et leur application - Google Patents
Dispositif à puce et instrument pour la détection d'acide nucléique, et leur application Download PDFInfo
- Publication number
- WO2023186084A1 WO2023186084A1 PCT/CN2023/085437 CN2023085437W WO2023186084A1 WO 2023186084 A1 WO2023186084 A1 WO 2023186084A1 CN 2023085437 W CN2023085437 W CN 2023085437W WO 2023186084 A1 WO2023186084 A1 WO 2023186084A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chamber
- sample
- nucleic acid
- amplification reaction
- chip device
- Prior art date
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 126
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 124
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 124
- 238000001514 detection method Methods 0.000 title claims abstract description 34
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 127
- 230000003321 amplification Effects 0.000 claims abstract description 126
- 238000006243 chemical reaction Methods 0.000 claims abstract description 108
- 239000000758 substrate Substances 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 30
- 238000012123 point-of-care testing Methods 0.000 claims abstract description 6
- 239000007788 liquid Substances 0.000 claims description 34
- 239000003153 chemical reaction reagent Substances 0.000 claims description 20
- 238000011901 isothermal amplification Methods 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 13
- 230000001404 mediated effect Effects 0.000 claims description 8
- 238000004020 luminiscence type Methods 0.000 claims description 6
- 238000004458 analytical method Methods 0.000 claims description 4
- 238000005415 bioluminescence Methods 0.000 claims description 3
- 230000029918 bioluminescence Effects 0.000 claims description 3
- 238000005401 electroluminescence Methods 0.000 claims description 3
- 238000006911 enzymatic reaction Methods 0.000 claims description 3
- 238000001917 fluorescence detection Methods 0.000 claims description 3
- 238000005166 mechanoluminescence Methods 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 238000005424 photoluminescence Methods 0.000 claims description 3
- 238000005395 radioluminescence Methods 0.000 claims description 3
- 238000005393 sonoluminescence Methods 0.000 claims description 3
- 238000000904 thermoluminescence Methods 0.000 claims description 3
- 239000013078 crystal Substances 0.000 claims 1
- 239000000523 sample Substances 0.000 description 90
- 239000007789 gas Substances 0.000 description 35
- 239000000243 solution Substances 0.000 description 24
- 238000000605 extraction Methods 0.000 description 15
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 12
- 239000000376 reactant Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 8
- 238000003752 polymerase chain reaction Methods 0.000 description 7
- 238000004321 preservation Methods 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 239000001569 carbon dioxide Substances 0.000 description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000003761 preservation solution Substances 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 230000004888 barrier function Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000012188 paraffin wax Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 208000035473 Communicable disease Diseases 0.000 description 3
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 101100240079 Severe acute respiratory syndrome coronavirus 2 N gene Proteins 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 206010043376 Tetanus Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 239000012472 biological sample Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 108091033319 polynucleotide Proteins 0.000 description 3
- 102000040430 polynucleotide Human genes 0.000 description 3
- 239000002157 polynucleotide Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 108010006464 Hemolysin Proteins Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000003228 hemolysin Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 241001678559 COVID-19 virus Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000186221 Cellulosimicrobium cellulans Species 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 101001018100 Homo sapiens Lysozyme C Proteins 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 108090000988 Lysostaphin Proteins 0.000 description 1
- 108010053229 Lysyl endopeptidase Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 208000032236 Predisposition to disease Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241001361634 Rhizoctonia Species 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000223260 Trichoderma harzianum Species 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000010669 acid-base reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000234 capsid Anatomy 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000023004 detection of visible light Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 210000003046 sporozoite Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/12—Apparatus for enzymology or microbiology with sterilisation, filtration or dialysis means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/34—Measuring or testing with condition measuring or sensing means, e.g. colony counters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/36—Apparatus for enzymology or microbiology including condition or time responsive control, e.g. automatically controlled fermentors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
Definitions
- the pressurized chamber increases the air pressure in the chamber through thermal expansion.
- thermal expansion generally refers to the phenomenon that the length or volume of a solid or liquid material changes due to a change in temperature when the pressure remains constant.
- the thermal expansion may be in the form of physical thermal expansion pressurization or chemical thermal expansion pressurization.
- the nucleic acid amplification reaction of the method is an isothermal amplification method, such as loop-mediated DNA isothermal amplification (LAMP).
- LAMP loop-mediated DNA isothermal amplification
- FIG. 2 is a schematic diagram of an exemplary chip device for detecting nucleic acids in samples provided by the present invention, configuring reagents and working after adding samples.
- FIG. 2A is a schematic cross-sectional view of an exemplary chip device for nucleic acid detection in samples provided by the present invention after reagents are configured therein.
- Figure 2B is a schematic diagram of the operation of the exemplary chip device after adding a sample.
- the invention provides a chip device for detecting nucleic acids in samples.
- the chip device is usually used to detect the presence and amount of nucleic acid in a sample after extracting and amplifying it.
- the chip device for nucleic acid detection in samples provided by the present invention includes a substrate 1, a sample chamber 2 arranged vertically on the substrate, and a pressurized chamber 3 arranged parallel to the sample chamber 2, and An amplification reaction chamber 4 is provided in the chip device substrate.
- the sample chamber 2 and the pressurizing chamber 3 are cylindrical chambers surrounded by walls perpendicular to the bottom plate.
- the sample chamber 2 and the pressurizing chamber 3 are connected through an air flow channel 5 .
- the sample chamber 2 is connected to the amplification reaction chamber 4 through the liquid flow channel 6 provided in the substrate below it.
- the bottom of the sample chamber 2 has an opening communicating with the liquid flow channel 6 provided in the bottom plate.
- the sample chamber 2 is used to accommodate the sample to be detected and to separate nucleic acids in the sample.
- the top of the sample chamber has an openable or closable cover, such as a nut 21 as shown in FIG. 1 , which has internal threads and is matched with external threads outside the sample chamber.
- the cover of the sample chamber is a gland, which has a handle fixedly connected to the sample chamber.
- the chip device for nucleic acid detection in this embodiment is particularly suitable for nucleic acid extraction from samples using the direct extraction method, that is, the solution obtained after the sample contacts and reacts with the nucleic acid extraction reagent contains nucleic acids that can be used for subsequent amplification reactions.
- Samples suitable for nucleic acid extraction and amplification using the direct extraction method include synthetic clones, in vitro transcribed RNA, plasmids, serum, plasma, urine, cotton swab eluates, sputum, alveolar lavage fluid and other samples .
- Nucleic acid extraction reagents used to extract the above samples usually contain lysis reagents, including various surfactants such as SDS, Triton, NP-40, etc., as well as other chemical reagents such as buffers, protease inhibitors, reducing agents, etc., as well as various lysis agents.
- lysis reagents including various surfactants such as SDS, Triton, NP-40, etc., as well as other chemical reagents such as buffers, protease inhibitors, reducing agents, etc., as well as various lysis agents.
- the main functions of the nucleic acid extraction reagent are: (1) using detergents to destroy lipid bilayers and rupture cells; (2) dissolve proteins; (3) promote protein denaturation; (4) inhibit proteases and nucleases. active.
- Commercially available direct-extraction nucleic acid extraction reagents include sample release reagent (model S1014) provided by China Shengxiang Biotechnology Co., Ltd.
- the amount of gas generated in the pressurized chamber 3 is the amount of original gas (i.e., volume) in the sample chamber 2 and the pressurized chamber 3, usually excluding the volume of the nucleic acid processing solution added to the sample chamber. ) about 1-50 times, preferably about 5-20 times.
- the air pressure in the pressurizing chamber 3 can be increased through thermal expansion, including physical thermal expansion pressurization or chemical thermal expansion pressurization.
- a filter element for filtering undesired substances (such as acidic gas or liquid) of the gas is provided in the air flow channel 5 or at its opening with the sample chamber 2 or the pressurized chamber 3 .
- the filter element is a filter membrane 51 disposed at the opening of the air flow channel and the pressurizing chamber 3 .
- the filter element is a filter column disposed in the air flow channel. More preferably, the shapes of the air flow channel and the filter column are set to gradually shrink from one end of the pressurizing chamber to one end of the sample chamber. This prevents the filter column from moving in the air flow path due to gas pressure.
- the filter element is made of filter material that can absorb acidic and/or alkaline substances.
- the workflow of the chip device for nucleic acid detection in samples is: open the cover of the sample chamber, put the sample to be tested (such as a throat swab), and A nucleic acid separation reaction is performed in the sample preservation solution, and the nucleic acid is released into the liquid; the pressurized chamber 3 is heated, and the heating causes the separation medium 81/83 to melt, and the first reactant 83 (for example, sulfuric acid) and the second reactant 84 (for example, sodium bicarbonate) contacts and reacts, and generates gas (such as carbon dioxide).
- the first reactant 83 for example, sulfuric acid
- the second reactant 84 for example, sodium bicarbonate
- the amplified nucleic acid is detected by detecting a fluorescent signal carried by the nucleic acid.
- the primers and oligonucleotides contained in the reaction system of the amplification reaction chamber can be radioactive, fluorescent or non-radioactive detectably labeled by methods well known to those skilled in the art. Commonly used fluorescent dyes and their signal-related wavelengths are shown in Table 1 below.
- a nucleic acid detection chip as shown in Figure 1 was prepared.
- the thickness of substrate 1 is about 2.0mm;
- the cavity volume of sample chamber 2 is about 1.6ml, and the inner diameter is about 7.0mm;
- the cavity volume of booster chamber 3 is about 1.2ml, and the inner diameter is about 7.0mm.
- the size of the cross-section of the liquid flow channel is approximately 0.4mm x 0.5mm.
- sample release agent (Changzhou Jinmag Biotechnology Co., Ltd., Su Chang Mechanical Preparation No. 20200123) into the sample chamber.
- the testing principle of the sample release agent is to use protein denaturants and biochemical reagents to quickly destroy the virus capsid structure in the throat swab sample, thereby causing the virus to cleave and release the nucleic acid; at the same time, the nucleic acid contained is stable
- the agent can effectively prevent the degradation of nucleic acids, thereby achieving the function of extracting and preserving nucleic acids.
- Applicable specimen types throat swab samples or body fluid samples.
- the reagents provided by Beijing Biolab Technology Co., Ltd.'s SARS-CoV-2 novel coronavirus RT-LAMP kit (N gene) were used as test reagents, including SARS-CoV-2N gene RT-LAMP positive control.
- the SARS-CoV-2N gene RT-LAMP primer mixture and 2 ⁇ LAMP MagicMix in the above kit are processed to form a freeze-dried powder and added to the amplification reaction chamber.
- the pressurized chamber is heated to about 70°C, the paraffin melts, HCl and NaHCO react to generate CO gas .
- the sample preservation solution is squeezed into the amplification reaction chamber through the flow channel. Reconstitute the amplification raw materials pre-placed in the amplification reaction chamber.
- a nasopharyngeal swab without SARS nucleic acid adsorption was added to another chip as a control.
- a nasopharyngeal swab without SARS nucleic acid adsorption was added to another chip as a control, and the remaining steps were the same as in the experimental group.
- the instrument has a chip device receiving and motion control system for receiving the chip device and performing various treatments on the chip, including heating treatment.
- the instrument may also have a signal detection module for detecting nucleic acid amplification products, such as a fluorescence detection system.
- the instrument has a system for temperature controlling the nucleic acid amplification area of the chip.
- the instrument has a nucleic acid amplification result analysis and/or output system.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Sustainable Development (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Clinical Laboratory Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
L'invention concerne un dispositif à puce pour la détection d'acide nucléique d'un échantillon, ledit dispositif étant pourvu d'un substrat, d'une chambre d'échantillon et d'une chambre de pressurisation, ainsi que d'une chambre de réaction d'amplification agencée dans le substrat. L'invention concerne en outre un instrument pour la détection d'acide nucléique d'un échantillon en utilisant le dispositif à puce, et en particulier un instrument POCT. L'invention concerne en outre un procédé de détection d'acide nucléique d'un échantillon à l'aide du dispositif à puce ou de l'instrument.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210329941 | 2022-03-31 | ||
CN202210329941.4 | 2022-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023186084A1 true WO2023186084A1 (fr) | 2023-10-05 |
Family
ID=88199485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2023/085437 WO2023186084A1 (fr) | 2022-03-31 | 2023-03-31 | Dispositif à puce et instrument pour la détection d'acide nucléique, et leur application |
Country Status (2)
Country | Link |
---|---|
CN (2) | CN116891800A (fr) |
WO (1) | WO2023186084A1 (fr) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5783148A (en) * | 1994-03-14 | 1998-07-21 | Becton Dickinson And Company | Nucleic acid amplification method and apparatus |
US5786182A (en) * | 1997-05-02 | 1998-07-28 | Biomerieux Vitek, Inc. | Dual chamber disposable reaction vessel for amplification reactions, reaction processing station therefor, and methods of use |
US20060222569A1 (en) * | 2003-04-25 | 2006-10-05 | Roland Barten | Device and method for the preparation of analyte comprising liquids |
CN101321867A (zh) * | 2006-03-24 | 2008-12-10 | 株式会社东芝 | 核酸检测盒及核酸检测装置 |
JP2015062361A (ja) * | 2013-09-25 | 2015-04-09 | 積水化学工業株式会社 | 核酸の増幅方法、並びに、核酸増幅用マイクロチップ |
JP2015062360A (ja) * | 2013-09-25 | 2015-04-09 | 積水化学工業株式会社 | 試料の加熱方法、並びに、マイクロチップ |
CN111607506A (zh) * | 2020-06-11 | 2020-09-01 | 上海前瞻创新研究院有限公司 | 一种薄膜式核酸扩增微流控芯片及其制备和应用方法 |
CN113492024A (zh) * | 2021-09-09 | 2021-10-12 | 中国医学科学院北京协和医院 | 一种带自驱动单元的微流控芯片、微流控方法及其应用 |
WO2021229582A1 (fr) * | 2020-05-14 | 2021-11-18 | Technion Research And Development Foundation Ltd. | Dispositif, systèmes, kits et procédés de détection rapide et simple d'agents pathogènes |
CN114085743A (zh) * | 2021-11-11 | 2022-02-25 | 杭州天微基因科技有限公司 | 全自动核酸处理扩增检测方法及磁控检测试管 |
-
2023
- 2023-03-30 CN CN202310330468.6A patent/CN116891800A/zh active Pending
- 2023-03-30 CN CN202320674930.XU patent/CN220703691U/zh active Active
- 2023-03-31 WO PCT/CN2023/085437 patent/WO2023186084A1/fr unknown
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5783148A (en) * | 1994-03-14 | 1998-07-21 | Becton Dickinson And Company | Nucleic acid amplification method and apparatus |
US5786182A (en) * | 1997-05-02 | 1998-07-28 | Biomerieux Vitek, Inc. | Dual chamber disposable reaction vessel for amplification reactions, reaction processing station therefor, and methods of use |
US20060222569A1 (en) * | 2003-04-25 | 2006-10-05 | Roland Barten | Device and method for the preparation of analyte comprising liquids |
CN101321867A (zh) * | 2006-03-24 | 2008-12-10 | 株式会社东芝 | 核酸检测盒及核酸检测装置 |
JP2015062361A (ja) * | 2013-09-25 | 2015-04-09 | 積水化学工業株式会社 | 核酸の増幅方法、並びに、核酸増幅用マイクロチップ |
JP2015062360A (ja) * | 2013-09-25 | 2015-04-09 | 積水化学工業株式会社 | 試料の加熱方法、並びに、マイクロチップ |
WO2021229582A1 (fr) * | 2020-05-14 | 2021-11-18 | Technion Research And Development Foundation Ltd. | Dispositif, systèmes, kits et procédés de détection rapide et simple d'agents pathogènes |
CN111607506A (zh) * | 2020-06-11 | 2020-09-01 | 上海前瞻创新研究院有限公司 | 一种薄膜式核酸扩增微流控芯片及其制备和应用方法 |
CN113492024A (zh) * | 2021-09-09 | 2021-10-12 | 中国医学科学院北京协和医院 | 一种带自驱动单元的微流控芯片、微流控方法及其应用 |
CN114085743A (zh) * | 2021-11-11 | 2022-02-25 | 杭州天微基因科技有限公司 | 全自动核酸处理扩增检测方法及磁控检测试管 |
Non-Patent Citations (1)
Title |
---|
SAFAVIEH EF, MANOJ K KANAKASABAPATHY, FARHANG TARLAN, MINHAZ U AHMED, MOHAMMED ZOUROB, WASEEM ASGHAR, HADI SHAFIEE : "Emerging Loop-Mediated Isothermal Amplification-Based Microchip and Microdevice Technologies for Nucleic Acid Detection", ACS BIOMATERIALS SCIENCE & ENGINEERING, vol. 2, no. 3, 14 March 2016 (2016-03-14), pages 278 - 294, XP055923541, DOI: 10.1021/acsbiomaterials.5b00449 * |
Also Published As
Publication number | Publication date |
---|---|
CN116891800A (zh) | 2023-10-17 |
CN220703691U (zh) | 2024-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2862224T3 (es) | Preparación de muestras para tipos de muestra difíciles | |
US8771955B2 (en) | Device and method for extraction and analysis of nucleic acids from biological samples | |
JP2008546401A (ja) | 自動医療診断用のカートリッジ、システム及び方法 | |
Kim et al. | A PCR reactor with an integrated alumina membrane for nucleic acid isolation | |
US20230227888A1 (en) | Point of need diagnostic device and methods of use thereof | |
WO2023274301A1 (fr) | Dispositif à puce et instrument pour la détection d'acide nucléique et son application | |
Qiu et al. | An integrated, cellulose membrane-based PCR chamber | |
Liu et al. | Toward rapid and accurate molecular diagnostics at home | |
KR20240013129A (ko) | 분석물 검출 카트리지 및 그 사용 방법 | |
WO2023186084A1 (fr) | Dispositif à puce et instrument pour la détection d'acide nucléique, et leur application | |
WO2023186159A1 (fr) | Dispositif et instrument à puce pour la détection rapide d'acides nucléiques et son application | |
JP2017509331A (ja) | 処理生物学的試料の保存等における改善 | |
Mamaev et al. | Method for automated extraction and purification of nucleic acids and its implementation in microfluidic system | |
JP4102149B2 (ja) | 核酸の分離精製装置 | |
JP2004180637A (ja) | 核酸の分離精製装置 | |
JP4130143B2 (ja) | 核酸の分離精製装置 | |
ES2295919T3 (es) | Procedimiento de extraccion de compuestos o complejos intracelulares a partir de una muestra que contiene una celulas en suspension en un liquido. | |
US20230160025A1 (en) | Point-of-care sars-cov-2 virus diagnostic device and methods of use thereof | |
DK1778863T3 (en) | INTEGRATED nucleic acid analysis | |
JP3819001B2 (ja) | 核酸の分離精製方法 | |
Juang et al. | Oil Immersed Lossless Total Analysis System (OIL-TAS): Integrated RNA Extraction and Detection for SARS-CoV-2 Testing | |
WO2021248053A2 (fr) | Dispositif de diagnostic du virus sars-cov-2 au point de soins et procédés d'utilisation de celui-ci | |
Rombach | Pre-storage of reagents for nucleic acid analysis in unit-use quantities for integration in Lab-on-a-chip test carriers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23778448 Country of ref document: EP Kind code of ref document: A1 |